Free testosterone has been shown to correlate better with androgen status than total testosterone. Assessment of free testosterone level has been recommended by all consensus best practice guidelines; however, its direct measurement is laborious and out of the scope of most clinical service laboratories. Calculating its level using some equations has been advocated in the absence of a direct measuring method. Androgen deficiency has been shown to be more prevalent in hemodialysis and renal transplanted patients compared to normal individuals. This study aimed to calculate free testosterone level in those patients using different equations to test whether these equations correlate with each other and with free androgen index. A significant discrepancy was found when these equations were compared with each other and when compared with free androgen index. In conclusion, free testosterone equations gave significantly discordant results when applied to male hemodialysis and renal transplanted patients. Therefore, we recommended validating these equations by free testosterone reference method before applying them to such patients.
INTRODUCTION
In men, testosterone is the most important and abundant androgen in blood (Saez, 1994) . Its deficiency has detrimental consequences on many organ systems (Greenspan et al., 1986; Jockenhovel et al., 1997; Davidson et al., 1979; Kapoor et al., 2005; Després et al., 1996) .
Endocrine abnormalities are a common feature of chronic renal insufficiency (Schaefer et al., 1992; Clodi et al., 1998) . Changes of testosterone synthesis and metabolism develop early after the onset of renal *Corresponding author. E-mail: drhhk@hotmail.com. Tel: 00963-8431111 Ext#: 1434. Fax: 009663-8423641.
insufficiency.
To avoid the consequences of hypogonadism in these patients a reliable index of androgenic status should be used.
Serum total testosterone may not always reflect the exact androgen status of a subject. Testosterone bound to SHBG is considered as biologically inactive (Anderson, 1974) ; therefore an estimate of the non-SHBG-bound fraction is considered a more reliable measure of androgen status. Free testosterone measurement is recommended as part of clinical evaluation for androgen deficiency by all consensus best practice guidelines (Bhasin et al., 2010; Petak et al., 2002; Nieschlag et al., 2005; Conway et al., 2000) . The reference method for estimating free testosterone is equilibrium dialysis (SinhaHikim et al., 1998) or centrifugal ultrafiltration (Hammond et al., 1980) . These methods are laborious and not suitable for a routine clinical service. Therefore, clinicians had to rely simply on the total testosterone or to use calculated indices of biologically available testosterone such as free androgen index (FAI) (FAI = total testosterone X 100/SHBG) (Wilke and Utley, 1987) or more complicated calculations to derive free testosterone concentration (Vermeulen et al., 1999; Sodergard et al., 1982) , which is more practical alternative and has lately been advocated (Diver, 2006) .
The performance of free-testosterone calculating equations in healthy subjects has already been evaluated. Up to our knowledge, this is the first study that investigates the performance of those those equations in diseased subjects known to have endocrine disturbance that encompasses impaired testosterone production and metabolism.
The current study aimed at calculating free testosterone level by three published equations in hemodialysis, renal transplanted patients, and age matched healthy individuals and to test whether they correlated with each other and with FAI.
PATIENTS AND METHODS

Subjects
Morning blood samples were withdrawn from 49 hemodialysis patients (pre-dialysis), 44 renal transplanted patients, and 63 agematched controls after obtaining ethical approval and informed written consents. Hemodialysis patients underwent regular polysulfone lowflux dialysis (Hemoflow F 7 HPS, Fresenius AG) three times a week (4 h/per session). Renal transplanted patients were on regular immunosuppressive medications: prednisolone from 5 to 10 mg/day, mycophenolate mofetil from 1 to 2 g/day, and cyclosporine A (trough level 129 ± 38.5 ng/ml) or tacrolimus (trough level 6.3 ± 1.9 ng/ml), according to the donor/recipient compatibility. The inclusion criteria for all participants were: male gender and age between 20-50 years. For hemodialysis patients, only those who have been on 3 times per week dialysis for more than 6 months have been included. Only renal transplanted patients with ≥ 6 months well-functioning graft (glomerular filtration rate > 60 ml per minute were included. We excluded any subject on testosterone replacement therapy, had diabetes mellitus, had history of endocrinological disorder, or liver disease. Any renal transplanted patient with history of graft rejection (that is, had features of rejection in graft biopsy, based on Banff criteria) was also excluded.
Biochemical investigations
Serum samples were assayed for urea; creatinine, sodium, potassium, glucose, and albumin were assayed by RxL Chemistry Analyzer (Dade Behring Inc, Newark, DE) . SHBG and serum total testosterone concentrations were measured by Architect i2000 analyzer (Abbott Laboratories, Chicago, IL) that employed Chemiluminescent Microparticle Immunoassay method (CMIA). The assay lower detection limit was 0.28 and 0.36 nmol/L for testosterone and SHBG; respectively. Total testosterone assay had 4.5 and 1.9% within-assay coefficients of variation (CV) at total testosterone concentrations of 2.84 and 17.5 nmol/L; respectively. The between-assay CV for total testosterone were 8.0 and 3.7% at total testosterone concentrations of 2.84 and 17.5 nmol/L; respectively. SHBG assay had 4.78 and 4.8% within-assay coefficients of variation (CV) at SHBG concentrations of 8.8 and 24.5 nmol/L; respectively. The total CV for SHBG were 9.5 and 5.7% at SHBG concentrations of 8.8 and 24.5 nmol/L; respectively. The other analytes
Free testosterone calculation
Three equations to calculate free testosterone (CFT) were compared in this study:
(1) Vermeulen et al. (1999) equation (CFTV):
Where T, S and A are total testosterone (nmol/L), SHBG (nmol/L) and albumin (g/L) concentrations, respectively, and N = 0.5217 A + 1.
They based their calculations on the law of mass action and verified the obtained free testosterone results by equilibrium dialysis measurement. The equation for calculated free testosterone was not reported in the original study, however, Ho et al. (2006) used the association constants of testosterone for SHBG (10 9 L/mol) and albumin (3.6 x 10 4 L/mol) quoted by the authors and derived the aforementioned equation.
(2) The Nanjee-Wheeler equation (CFTNW) which they derived from regression analysis of free testosterone concentrations measured by a gel filtration method in serum samples from 100 normal men and 18 normal women (Nanjee and Wheeler, 1985) . Statistical treatment of the original data took into account the changes of testosterone and SHBG but not albumin concentration and yielded the following equation: CFTNW = T X (6.11 -2.38 x log10 S) where T and S are total testosterone and SHBG concentrations, respectively (nmol/L). Where S: is SHBG in nmol/L and T: is total testosterone in nmol/L. In the same study, they evaluated the predictive accuracy of CFTZ and other four equations including CFTV and CFTNW using a database of nearly 4000 consecutive blood samples from a routine diagnostic laboratory. Free testosterone was measured by centrifugal ultra-filtration, a centrifuge-accelerated form of equilibrium dialysis (Vlahos et al., 1982) . Total testosterone and SHBG levels were measured by immunoassays on every sample included in that study. They concluded that CFTZ had a high predictive accuracy in both model fit and predictive error estimation. CFTZ was also found by Ly P et al. (2010) to have the best predictive accuracy relative to the classical equilibrium dialysis method, the one without ultracentrifugation.
Calculation of the FAI requires the measurement of total testosterone and SHBG and is defined by the following equation (Carter et al., 1983) :
Where T: is total testosterone (nmol/L) and S: is SHBG (nmol/L). inter-quartile range, *: median score is significantly different among each of the three groups, **: controls median score is significantly lower than those of hemodialysis and renal transplanted patients while there was no significant differ ence between the later two groups, ‡: median score of hemodialysis patients is significantly lower than those of controls and renal transplanted ones while there was no significant difference between controls and renal transplanted patients, ¶: controls median score is significantly higher than those of hemodialysis and renal transplanted patients while there was no significant difference between the later two groups , CFTV: Vermeulen equation , 
Statistical analysis
All statistical analyses were carried out using SPSS PC+ version 13.0 statistical software and version 11.5.1.0 MedCalc software. Normality of the distribution of measured variables was assessed by Kolmogorov-Smirnov and Shapiro-Wilk tests at α level of 0.05. Normally distributed variables were described using mean ± standard deviation (SD) and compared across the three groups using Analysis of Variance (ANOVA). Contrast testing was used to detect the pair of the normally distributed variable that had a significant mean difference. Variables that were found by normality testing to have significant departure from normality were expressed using median and inter-quartile range (IQR). Medians of the later type of variables were compared across groups using KruskalWallis test followed by Pairwise analysis testing to determine the pair with significant median difference. Comparison of CFT levels derived by the three equations within each group was performed using Friedman test and Pairwise analysis. p < 0.05 was considered statistically significant.
RESULTS
Clinical features and biochemical investigations for the three groups were summarized in Table 1 . There was no significant age difference between the three groups (p = 0.61). Expected differences in blood pressure and some routine biochemical investigations (e.g. urea, creatinine, sodium, albumin, and hemoglobin) were evident between the groups. Total testosterone did not differ significantly between the groups (p = 0.399), while SHBG level was significantly (p = 0.002) higher in hemodialysis and renal transplanted patients than in controls. FAI was significantly (p = 0.028) higher in the control group compared to the patients groups (hemodialysis and renal transplanted patients) while no significant difference was found between patients groups. Calculated free testosterone derived by CFTV and CFTZ was not significantly (p = 0.404 and p = 0.522; respectively) different across the three groups (Table 2) . CFTNW gave calculated free testosterone value that was significantly different across the groups, showing that calculated free testosterone of renal transplanted men (Table 2 ) was significantly (p < 0.0001) higher than both control and hemodialysis groups and the later two groups had calculated free testosterone levels that were not significantly different from each other.
Detailed statistical descriptions (means, medians, SD, IQR, and percentiles) of total testosterone, SHBG, albumin, FAI, and free testosterone levels obtained by the three equations were summarized in Table 3 .
The significance of the differences between calculated free testosterone values derived by the three equations within each group was illustrated in Figure 1 . It was Al-Khallaf et al. shown that in control, dialysis, and transplant groups; the significance of differences between calculated free testosterone measured by the three equations was p < 0.0001, p < 0.001, and p < 0.001; respectively. Figures 2A, 2B and 2C are the illustration of those differences by Bland-Altman plot where it was shown that across the three groups CFTV was always giving calculated free testosterone values higher (mean = 0.12-0.14, 1.96 SD = 0.12-0.27) than CFTZ. It also showed that across the three groups, CFTV was always giving calculated free testosterone values higher (mean = 0.12-0.20, 1.96 SD = 0.15-0.38) than CFTNW. When it came to the difference between CFTZ and CFTNW, it showed that in control and dialysis groups, CFTZ was always giving higher calculated free testosterone values (mean = 0.07, 1.96 SD = 0.07-0.11) than CFTNW, but in transplant group this difference was reversed making CFTNW gives higher results (mean = 0.16, 1.96 SD = 
0.13) than CFTZ.
In each group, the regression equations describing the relationships between the corresponding pair of equations were summarized in Figures 2D, 2E and 2F. It shows that across the three groups the regression line between CFTV and CFTZ had a slope that varied from 1.6 to 1.9 and an intercept between -0.03 and -0.11. In control and hemodialysis group, the relationship between CFTV and CFTNW was represented by a slope that varied from 2.24 to 2.53 and an intercept that varied groups was illustrated in Figure 3 . Based on the area under curve (AUC), it was shown that the performance of the three equations was better in transplant group compared to dialysis group. CFTV ROC had the least AUC among dialysis and transplant groups. In dialysis group, the largest AUC belonged to CFNW equation, while in transplant group CFTZ had the largest AUC.
DISCUSSION
This study investigated the performance of three freetestosterone calculating equations when applied on dialysis and renal transplanted patients. Although these equations use entries (i.e. total testosterone, SHBG, and albumin) that have been standardized in terms of methods used to obtain their concentrations, they still exhibited statistically significant different ranges and medians even when applied within the same group (Tables 2 and 3 ). This finding reinforced the importance of establishing a distinctive reference range for each equation. It has even been recommended, due to the remarkable inter-assay variability of total testosterone and SHBG, to have different reference ranges for the same equation corresponding to the method used to assay total testosterone and SHBG. The reference range derived for Vermeulin equation (CFTV) in this study is exclusive to that equation and only valid for samples in (Figure 1) showed that these equations gave calculated free testosterone levels that were significantly different from each other within all three groups. That comparison also showed that in control and dialysis groups, CFTV gave higher result (mean difference = 0.12 nmol/L in control and 0.14 nmol/L in dialysis group) than that of CFTZ that in turn gave a higher calculated free testosterone level (mean difference = 0.07 nmol/L in both control and dialysis group) than CFTNW ( Figures 2A, 2B and 2C) . In other words, in control and dialysis group this order was maintained: CFTV > CFTZ > CFTNW. In renal transplant group, the relation of CFTV > CFTZ did not change, but unexpectedly CFTNW equation gave the highest calculated free testosterone values among the three equations changing the order to be CFTNW > CFTV > CFTZ. This dramatic change was also evident in Figures  2D, 2E and 2F , where the slope of the regression curve describing the relationship between CFTV and CFTNW dropped from 2.25 in control and 2.53 in dialysis to 1.04 in transplant group. This slope change was even clearer when we looked at the three slopes of the regression lines describing the relationship between CFTZ and CFTNW, where the slope has changed from 1.41 in control and 1.42 in dialysis (almost identical slopes) to 0.58 in transplant group. Both CFTZ and CFTNW rely only on total testosterone and SHBG to calculate free testosterone level (no entry for albumin level is needed) and they are both empirically derived, but CFTZ has been validated by ultra-filtration and equilibrium dialysis reference methods, while CFTNW was validated by gel filtration method. However, CFTZ had consistent performance in terms of reporting calculated free testosterone values that are consistently lower than CFTV in all three groups, while CFTNW gave lower calculated free testosterone values than both other two equations in control and dialysis groups, but started to give higher results than both of them when applied to transplanted patients. This discrepancy manifested itself in another way when we considered FAI as a reference method for diagnosing hypoandrognic subjects and compared the diagnostic utility of the three equations with it ( Figure 3) . The diagnostic utility of each equation was represented by ROC curve where the AUC was proportional to the respective equation. It was clear that the three equations had better performance when applied to transplanted patients compared to dialysis ones. It was also clear that in both dialysis and transplant groups, CFTV had the worst performance among the three equations.
The best performance in dialysis group was that of CFTZ, while in transplant group CFTNW had the best performance. When ordering these three equations based on the corresponding AUC we get in dialysis group this order: CFTNW > CFTZ > CFTV, while in transplant group the order is: CFTZ > CFTNW > CFTV. This unexplained change of order is another form of discordance we found between these equations.
When CFTV, CFTZ, CFTNW and FAI were used to compare the three groups (control, dialysis, and transplant groups) according to their corresponding calculated free testosterone levels, CFTV and CFTZ did not show any significant difference between these groups (Table 2) . On the other hand, CFTNW ordered them as transplant group > (control group = dialysis group) and FAI ordered them as: control group > dialysis group > Al- Khallaf et al. 15 transplant group. It is obvious that even after standardizing the methods used to derive their required entries, these equations gave discordant results when compared to each other and when compared to FAI. Since we did not measure the exact free testosterone level using a reference method, we could not tell for sure whether FAI or one of the CFT equations was giving the correct order.
In conclusion, calculation of free testosterone rather than its laborious direct measurement is a practice that has recently been gaining more popularity especially after been advocated by some researchers and after the emergence of more calculating equations. Some of these equations are supported by studies that validated them against reference methods. However, most of these studies if not all have experimented the validity of these equations on normal subjects. This study showed that when applying some of these equations on diseased subjects such as dialysis and renal transplanted patients, a significant discrepancy between them is found, which demands that such calculation practice should not be carried out in diseased people without prior validation of the equation to be used. Without comparison against a reference method, we could not prove the superiority of an equation over another or whether FAI was superior to those equations, however, the absence of such comparison does not invalidate the discrepancy found in this study.
We hope that this study would encourage other researchers to explore the validity of other equations in other diseased subjects and would alert healthcare givers about the use of these equations on patients without validating them first.
